Pfizer OTC, page-48

Absolutely aug. But my post was responding to why the market is "ignoring" not implying there's a "run of the mill" research grant program for anything that might possibly look like a go.

I stand by my comments. There is a common process. Pharma's have a large budget to target particular types of technology R&D that fits their strategy. This strategy of R&D in the large pharma sector has been around a long time now and is also used in other sectors because it is more cost effective and efficacious for identifying solid opportunities. The process actually is "routine". From their side it's routine. From our side it's pretty exciting. From the market's side it's wait and see because many of these research relationships do not progress.

here, this one even has an interview with Pfizer
https://www.thebalance.com/who-funds-biomedical-research-2663193